Clinical Trial Update: Lovastatin as a Neuroprotective Treatment for Early Stage Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating lovastatin as a neuroprotective treatment for early-stage Parkinson's disease; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Lovastatin (Lovastatin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Parkinson Disease | Phase 2 | Status: UNKNOWN